Fresenius SE & Co. (OTCMKTS:FSNUY) Sees Large Volume Increase – Still a Buy?

Posted by Hanz Christensen on Jul 23rd, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) saw unusually-strong trading volume on Thursday . Approximately 751,299 shares changed hands during mid-day trading, an increase of 420% from the previous session’s volume of 144,600 shares.The stock last traded at $12.25 and had previously closed at $12.46.

Analyst Ratings Changes

Separately, Morgan Stanley reaffirmed an “overweight” rating on shares of Fresenius SE & Co. in a research note on Tuesday. Three analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has a consensus rating of “Buy”.

Get Our Latest Research Report on Fresenius SE & Co.

Fresenius SE & Co. Stock Performance

The company has a market cap of $27.60 billion, a P/E ratio of 16.33 and a beta of 0.63. The company has a quick ratio of 0.98, a current ratio of 1.27 and a debt-to-equity ratio of 0.41. The firm has a 50 day moving average of $11.47 and a 200-day moving average of $12.88.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.24 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). Fresenius SE & Co. had a return on equity of 10.09% and a net margin of 6.55%.The business had revenue of $6.75 billion during the quarter, compared to analysts’ expectations of $6.79 billion. As a group, sell-side analysts anticipate that Fresenius SE & Co. will post 1.03 EPS for the current fiscal year.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.